ENHANCIN

This brand name is authorized in Nigeria. It is also authorized in Ecuador, Lithuania, Romania, Singapore.

Active ingredients

The drug ENHANCIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Amoxicillin trihydrate UNII 804826J2HU - AMOXICILLIN
	Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.
	Read more about Amoxicillin
2	Clavulanic acid UNII Q42OMW3AT8 - CLAVULANATE POTASSIUM
	Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
	Read more about Clavulanic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2105	Tablet	Enhancin 625 Tablets TAB 500 mg; 125 mg 1 x 10's (in blister)	Film-coated tablet	24/06/2021
04-2767	Powder for injection	Enhancin Injection 1.2 g Co-Amoxiclav for Injection BP INJ_PWD 1000 mg; 200 mg 1.2 g x 1's (in vial)	Powder for Solution for Injection in a vial	28/03/2023
04-7730	Tablet	Enhancin 375 Tablets TAB 250 mg; 125 mg 2 x 10's (in blisters)	Film-coated tablet	24/06/2021
04-9025	Tablet	Enhancin Tablets 1 g TAB 875 mg; 125 mg	Film-coated tablet	26/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CR02	Amoxicillin and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.048-04-03, 25.059-04-03, 25.124-05-03, 29439-11-10
LT	Valstybinė vaistų kontrolės tarnyba	1003006, 1004174
NG	Registered Drug Product Database	04-2105, 04-2767, 04-7730, 04-9025
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59497001, W59497002, W59497003, W59497004, W59497005, W59497006, W59497007, W59497008, W59497009, W59497010, W59497011, W59497012, W65768002
SG	Health Sciences Authority	11027P